Klimaktoplan^® (Tablets) Instructions for Use

Marketing Authorization Holder

Deutsche Homöopathie Union, GmbH & Co. KG (Germany)

ATC Code

G02C (Other drugs used in gynecology)

Dosage Form

Klimaktoplan®

Tablets: 100 pcs.

Dosage Form, Packaging, and Composition

Tablets are gray (to light gray), flat-cylindrical, with a bevel, without a distinct odor, and in rare cases may have inclusions.

Excipients: lactose monohydrate, talc, magnesium stearate, wheat starch.

20 pcs. – blisters (5) – cardboard packs.

Clinical-Pharmacological Group

Homeopathic preparation used for menopausal syndrome

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

It is a homeopathic preparation used for menopausal syndrome. It exerts an estrogen-like effect by binding to estrogen receptors of hypothalamic neurons (affecting the hypothalamus-pituitary-ovaries system).

This leads to a decrease in the secretion of luteinizing hormone (LH) by the anterior pituitary gland. The reduction in gonadotropin release leads to the elimination of psychoemotional and vegetative-vascular disorders (such as hot flashes, tachycardia, increased nervous excitability, dizziness, headache) that occur in the premenopausal and menopausal periods and are caused by a sharp decrease in estrogen production with a simultaneous increase in the secretion of LH and FSH.

The preparation also has a sedative effect, normalizing sleep and mood.

The preparation is not intended for replacement therapy.

Pharmacokinetics

The pharmacokinetics of the drug Klimaktoplan^® have not been studied.

Indications

• As part of the complex therapy of menopausal syndrome (hot flashes, increased sweating, palpitations, dizziness, itching, nervous tension, sleep disorders).

ICD codes

Dosage Regimen

Take 1 to 2 tabletsthree times daily.

Administer the tablets 30 minutes before or 30 minutes after a meal.

Allow the tablets to dissolve slowly in the mouth; do not swallow them whole.

The duration of therapy is determined by the physician based on the severity of symptoms and clinical response.

Discontinue use and consult a physician if symptoms worsen or if no improvement is observed after a course of treatment.

Adverse Reactions

Possible allergic reactions.

Contraindications

• Hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

If it is necessary to use the drug Klimaktoplan^® during pregnancy and lactation, the expected benefit for the mother should be weighed against the potential risk to the fetus.

Special Precautions

When using Klimaktoplan^®, a temporary worsening of the condition is possible. In this case, the patient should discontinue the drug and consult a doctor.

The patient should be informed that in the absence of a therapeutic effect, the drug should be discontinued and a doctor should be consulted.

Overdose

To date, no cases of overdose with the drug Klimaktoplan^® have been reported.

Drug Interactions

Drug interactions of the drug Klimaktoplan^® have not been described.

Storage Conditions

The drug should be stored in a dry place at room temperature.

Shelf Life

The shelf life is 4 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.